Valor Medical
>> Sunday, January 3, 2010
Valor Medical is developing a filler technology for occluding vascular leaks and aneurysms. The patent pending technology is a based on derivative of a cyanoacrylate monomer that polymerizes on contact with blood.
Valor’s first product, Neucrylate, will be indicated for treating cerebral aneurysm, and coil salvage. The company received approval to begin the first human trial in Europe. Read more...
